๏◡๏♡ try 1ClickGram.com download instagram videos and photos

Dr. Garcia on FDA Approval of Pembrolizumab in Bladder Cancer

Say and pronounce Dr. Garcia On on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Jorge Garcia, MD, Department of Hematology and Oncology, Cleveland Clinic, discusses the May 2017 FDA approval of pembrolizumab (Keytruda) in patients with urothelial carcinoma.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You

Related

  Dr. Balar on the Approval of Pembrolizumab for Bladder Cancer   FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More   Durvalumab FDA Approval for Bladder Cancer   The FDA Approval of Atezolizumab in Bladder Cancer   Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma   21st Century Cures Act Passes and 2016 Highlights from SABCS and WCLC   Dr. Grothey on FDA Approval of Pembrolizumab in MSI-High CRC   FDA Approval of Durvalumab for Bladder Cancer   Dr. Spigel on FDA Approval of Pembrolizumab/Chemo Combo in NSCLC   FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More   Upfront Use of Immunotherapy for NCSLC   Pembrolizumab in Newly Diagnosed Squamous NSCLC   Dr. Wakelee on FDA Approval of Frontline Pembrolizumab in NSCLC   Dr. Plimack on Combo of Pembrolizumab/Epacodostat in Bladder Cancer   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and Breakthrough Designation in NSCLC   FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC   FDA Approval in AML, NDA Submitted in Myeloma, Clinical Hold on CAR T-cell Therapy Trials, and More   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   Upfront Immunotherapy for PD-L1+ NSCLC   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   Dr. Steinberg on the FDA Approval of Atezolizumab in Bladder Cancer   FDA Approval of Durvalumab for Advanced Bladder Cancer   Combined Immunotherapy and Chemotherapy for NSCLC   Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More   Upfront Immunotherapy + Chemotherapy for NSCLC   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   Dr. Bendell on FDA Approval of Regorafenib in Liver Cancer   FDA Approval of Atezolizumab for Advanced Bladder Cancer   Upfront Immunotherapy for NSCLC   Dr. Garcia on Selecting Second-line Immunotherapy in Bladder Cancer   Immunotherapy for HNSCC   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   Dr. Garcia on Sequencing Immunotherapies in Bladder Cancer   Breakthrough In Leukemia Treatment   FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More   FDA Approval in Lung Cancer, Priority Reviews in HCC and NHL, and an ODAC Recommendation   Novartis Metastatic Breast Cancer Treatment   Dr. Plimack on the Challenges With Available Immunotherapies for Bladder Cancer   FDA Approvals in CRC, Blood Cancer Detection Diagnostic, and Alopecia, and More   FDA Approvals in Breast Cancer and Melanoma, Disappointing Results in HNSCC, and More   FDA Approvals in CRC, Blood Diagnostic, and Alopecia, and More   FDA Approval: Frontline Ceritinib for ALK+ NSCLC   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   FDA Approval in CLL, Recommendation in NSCLC, Missed Endpoint in GBM Study, and More   Activity of Immunotherapy in the Frontline Setting   FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More   Dr. Gandhi on Pembrolizumab/Chemo Findings in NSCLC and FDA Approval   Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   Bladder Cancer Recurrence Discovered Through New Urine Test   Dr. Blackwell on Neratinib in HER2+ Breast Cancer   'Our Cancer Drug Is For Rich Westerners, Not Poor Indians'   Frontline Atezolizumab for Advanced Bladder Cancer   FDA Approval of Brigatinib for ALK+ NSCLC   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   2015 AACR Annual Meeting Highlights   FDA approves breakthrough CAR-T therapy for leukemia   Dr. Randy Sweis on Impact of Atezolizumab Approval in Bladder Cancer   FDA Approval in Lung Cancer, Promising Findings in Hodgkin Lymphoma, and More   Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC   Bradley C. Leibovich, M.D.: Urologist - Mayo Clinic   Dr. Brammer on FDA Approval of Brentuximab Vedotin in CTCL   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Dr. West on FDA Approval of Brigatinib in ALK+ NSCLC   Dr. Al-Kali on FDA Approval of Enasidenib in AML   Dr. Gomella on Ongoing Trials of Immunotherapy in Bladder Cancer   FDA Approval in AML, Priority Review Designation in NSCLC, and More   Niraparib Maintenance for Recurrent Ovarian Cancer   Dr. Black on Sequencing of Immunotherapy in Bladder Cancer   Dr. Reidy-Lagunes on FDA Approval of Telotristat Epitrate for Carcinoid Syndrome   FDA Approvals in ALL and Breast Cancer, Priority Reviews in CML and Follicular Lymphoma, and More   Dr. Rosenberg on Future Use of Atezolizumab in Bladder Cancer   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More

Popular Today

  We snag our first TOP 10!   Better call with a Conservative Caller on Filibuster and DC Statehood   Working Woman Testifies About Reality Of Poverty In The U.S. | NowThis   Monza Time Trial 1:09.201   NASCAR Next-Gen: The Future is Now   New Video Out Now! This Time It's All About Street Circuits That Never Came To Be, With Proposals From Formula 1, IndyCar, and More! Let Me Know What You All Think, Feedback is Greatly Appreciated!   Bmw S1000rr Engine Blow   Can I Beat Pole? F1 Portugal 2021 | Assetto Corsa   tomac to yamaha   NASCAR's new state of the art racecar to be revealed by 3PM EST   Romain Grosjean to Test the Mercedes Championship Winning car at French GP Weekend   Circuit de Catalunya Weekly Time Trial   水素エンジン搭載のトヨタ カローラ・スポーツがS耐公式テストに登場! hydrogen combustion engine technology   f1 2021 Portugal Grand Prix reaction!   Full Race Speedway GP Poland 1st League 2021 REPLAY   I made a video showing you the cheapest way to go door to door racing!   [Video] MotoGP Spanish Grand Prix highlights   [054] How Old Is Your Normal Match Racket? - Let's Talk Squash   How To Be Mayor Of London   Trump Censorship and Baby Debate push Tyler to mental limit   Philippines FM Curses Out China “GET THE $#&! OUT!” | EU-China Deal Dead?   Social Roles & Alienation   Federal Judge Calls Out Bill Barr For Lying About Muller Report   Libertarian Icon Larry Reed Recollects His Time As an Anti-Communist Fighter   Airtricks Are Cool! - Change My Mind!   Social media reacts to the Olympics banning BLM apparel   Dan McKnight on the Defend the Guard Movement - Part Of The Problem   Colombian state violence and its imperialist role destabilizing the region   Russia Accused of Rights Violations in CAR, Time to Pay Africa Reparatio...   This mans is tryna say the LGBT community is turning all black men gay so there are less black families in America.....   A review of the literature on the psychology of conspiracy theories found that belief in conspiracies is driven by their “promise to satisfy important social psychological motives that can be characterized as epistemic, existential, and social” (Douglas et al. 2017)   It's this Summer or Never   X-Factor Winner Reveals World's Secret Religion   The Uncommitted (Ep. 8): Bates vs Duren, Holmgren & Sallis to Zags, Major Transfers & Coaching Hires   Very candid Interview with Matt Doherty about his time as UNC Head Coach - Culture State Podcast   Is Anarchy order or chaos?   Anarchism101, what is hierarchy   Noname's Revolutionary Message   Why Capitalism is killing us (And The Planet)   Mr Beast Refinable crypto SCANDAL? Ethereum soars over $3k | The Chew Over w/ Nic & Jay ep 3 Crypto   Monica Abbott's Career Journey   #RPMPodcast Episode 14 (skipping unlucky number 13 for obvious reasons) Featuring Eddie Wood is LIVE!!   Throwback to Kevin Harvick at Rockingham qualifying circa 2001   Remembering John's Andretti's 1999 Victory   MKBHD - What Is Right To Repair?   Rightwing reporter tries to lie to Jen Psaki and INSTANTLY regrets it [Brian Tyler Cohen on YouTube]   Rhiannon Giddens on Blending Irish, Italian, and American Music   Mini Cannon Build   Turbo Hamster   The sound of projectiles   View All Today's Popular Videos